Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9012618
Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity whi
granted patentUS 9012647
Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treat
granted patentUS 9006203
Method of reducing inflammatory infiltration in subjects with inflammatory lung disease
granted patentUS 9005631
Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle
granted patentUS 9005604
Aligned and electrospun piezoelectric polymer fiber assembly and scaffold
granted patentUS 8999352
Genetically engineered swine influenza virus and uses thereof
granted patentUS 9000141
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito
granted patentUS 8999290
Papillomavirus pseudoviruses for detection and therapy of tumors
granted patentUS 8999336
Monoclonal antibodies against Orthopoxviruses
granted patentUS 8993626
Methods of treatment using sterculic acid
granted patentUS 8993768
Tropolone compounds for treating or preventing retroviral infection
granted patentUS 8992943
Vaccine for protection against Shigella sonnei disease
granted patentUS 8986695
Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vBβSauS-philPLA
granted patentUS 8986708
Combinations of gene deletions for live attenuated Shigella vaccine strains
granted patentUS 8986757
Essential oils inhibit mold on wood
granted patentUS 8987296
Acridone compounds
granted patentUS 8987426
Immunotoxin fusion proteins and means for expression thereof
granted patentUS 8980952
Methods for treating brain swelling with a compound that blocks a non-selective cation cha
granted patentUS 8980871
Methods of treatment for hemolysis
granted patentUS 8980859
Aegyptin and uses thereof
granted patentUS 8975231
Bone morphogenic protein binding peptide
granted patentUS 8968719
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted patentUS 8961975
Monoclonal antibodies that neutralize anthrax toxins
granted patentUS 8961989
Methods for producing an immune response to tuberculosis
granted